Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
8.71
-0.71 (-7.54%)
At close: Aug 28, 2026, 4:00 PM EDT
8.77
+0.06 (0.69%)
After-hours: Aug 28, 2026, 7:40 PM EDT
Absci Employees
Absci had 140 employees as of December 31, 2025. The number of employees decreased by 17 or -10.83% compared to the previous year.
Employees
140
Change (1Y)
-17
Growth (1Y)
-10.83%
Revenue / Employee
$11,150
Profits / Employee
-$864,836
Market Cap
1.49B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 140 | -17 | -10.83% | 140 | 0 |
| Dec 31, 2024 | 157 | 1 | 0.64% | 156 | 1 |
| Dec 31, 2023 | 156 | -37 | -19.17% | 155 | 1 |
| Dec 31, 2022 | 193 | -19 | -8.96% | 193 | 0 |
| Dec 31, 2021 | 212 | 110 | 107.84% | 211 | 1 |
| Sep 30, 2021 | 207 | 105 | 102.94% | 207 | 0 |
| Jun 30, 2021 | 169 | - | - | 169 | 0 |
| Mar 31, 2021 | 102 | - | - | 102 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innoviva | 159 |
| Maze Therapeutics | 141 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
| Tyra Biosciences | 87 |
| ArriVent BioPharma | 77 |
| Apnimed | 65 |
| Avalyn Pharma | 55 |
ABSI News
- 11 days ago - Absci reports Q2 EPS (21c), consensus (20c) - TheFly
- 17 days ago - Absci Earnings Call Transcript: Q2 2026 - Transcripts
- 17 days ago - Absci Earnings release: Q2 2026 - Filings
- 17 days ago - Absci Quarterly report: Q2 2026 - Filings
- 17 days ago - Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results - GlobeNewsWire
- 17 days ago - Absci Slides: Corporate presentation - Filings
- 5 weeks ago - Absci management to meet virtually with KeyBanc - TheFly
- 6 weeks ago - Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 - GlobeNewsWire